mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.001 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |